PropertyValue
?:abstract
  • INTRODUCTION Severe acute respiratory syndrome coronavirus-2 may escape the inactivation by gastric acid because of hypochlorhydria caused by proton pump inhibitors (PPIs), which could predispose the patients to severe COVID-19. METHODS We studied the association between prehospitalization PPI exposure and clinical outcomes among hospitalized COVID-19 patients. RESULTS A total of 295 hospitalized COVID-19 patients were included in the study. 15.6% of hospitalized COVID-19 patients were on PPIs at home. Mortality among PPI-users was 2.3 times higher than non-users, along with 2.3 times higher risk of acute respiratory distress syndrome after adjusting for confounding variables. CONCLUSION We found that prehospitalization PPI-exposure is independently associated with worse clinical outcomes, including mortality in COVID-19 patients, regardless of the presence of cardiovascular comorbidities.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1097/meg.0000000000002013
?:journal
  • European_journal_of_gastroenterology_&_hepatology
?:license
  • unk
?:pmid
?:pmid
  • 33252418
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
?:type
?:year
  • 2020-11-30

Metadata

Anon_0  
expand all